Science You Can Trace
ACEND formulas are built from peer-reviewed evidence, mapped to pathways, and designed for real-world use. Explore how ingredients, delivery systems, and nutritional targets come together in CI-1—and in future formulas as they launch.
Understand what the body is signaling and which nutritional levers matter.
See why each ingredient is included and what evidence supports its role.
earn what to track (start with a simple baseline), what each marker can suggest, and how to follow trends over time—so the pathways become measurable.
Chronic Inflammation
A practical overview of inflammatory signaling, resilience breakdown, and the nutritional inputs used in CI-1.
Polyphenols + The Gut Microbiome
Many polyphenols are only partially absorbed in the small intestine and reach the colon, where gut microbes transform them into smaller metabolites. This microbiome-driven conversion can support gut barrier conditions, immune steadiness, and systemic resilience pathways.
Pathway Science
A systems-level library that explains how core networks interact - Gut-Immune Axis, Neuroimmune Crosstalk, and Mitochondrial Signaling - with clear links to ingredient deep dives
Explore the rationale for each ingredient—what it does, why it’s included, and any bioavailability considerations.
Our Evidence Standard
Prioritize human data where available.
Use mechanistic data to explain plausibility, not as proof.
Use clinically realistic doses, and disclose when a benefit depends on absorption support.
Avoid single-marker thinking and map ingredients to multi-pathway resilience.
For Practitioners
Access ingredient rationales, protocols, and product documentation designed for clinical conversation.
Questions,
Answered.
No. The Science Hub is educational and explains the nutritional rationale behind ACEND formulas. For medical decisions, consult a licensed clinician.
We prioritize human evidence where available and use mechanistic data to explain how and why an ingredient may be relevant. We are conducting our own human clinical studies on ACEND-CI in 2026 and will publish this data once available.
Some compounds have poor natural absorption. Delivery-limited indicates that uptake may constrain real-world effect.
As evidence evolves and new products created, we will update the content to reflect our current methods and offerings. Our newsletters will also post pertinent updates.
Ready to start with CI-1?
CI-1 is designed to support whole-body inflammatory load with multi-pathway
inputs and transparent ingredient rationale
